<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03424824</url>
  </required_header>
  <id_info>
    <org_study_id>P15-01 / BP1.3656</org_study_id>
    <secondary_id>2017-000069-57</secondary_id>
    <nct_id>NCT03424824</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment</brief_title>
  <official_title>A Multisite Randomized Clinical Trial Evaluating BP1.3656 Vs Placebo For Alcohol Use Disorder Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bioprojet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bioprojet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proof of concept study evaluating in alcohol use disorder, the ability of psychosocial
      support in combination with BP1.3656 to reduce alcohol consumption. The study will be a
      multicenter, randomized, double-blind, placebo-controlled phase II trial with parallel groups
      to evaluate the effectiveness and the safety of BP1.3656.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in number of monthly Heavy Drinking Days (HDDs/month)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Decrease in number of monthly heavy drinking days (HDD/month) from baseline to the end of the double blind Randomized Treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total daily alcohol consumption (TAC)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Total daily alcohol consumption (TAC) from baseline to the end of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of patients without Heavy Drinking Days (HDDs)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Percent of patients without HDDs during the 12-week medication phase</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">129</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>BP1.3656 low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BP1.3656 intermediate dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BP1.3656 low dose</intervention_name>
    <description>Tablet, once daily oral administration at the low dose</description>
    <arm_group_label>BP1.3656 low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BP1.3656 intermediate dose</intervention_name>
    <description>Tablet, once daily oral administration at the intermediate dose</description>
    <arm_group_label>BP1.3656 intermediate dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Tablet, once daily oral administration</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female alcohol use disorder

          -  Ages 18-65

          -  Absent or minimal alcohol withdrawal symptoms assessed

          -  18 kg/m2 ≤ BMI ≤ 35 kg/m2

          -  Excessive alcohol use during the 2 weeks between screening and baseline

          -  Voluntarily expressed willingness to participate in the study, understanding protocol
             procedures and having signed and dated an informed consent prior to the start of
             protocol required procedures while not intoxicated (BAC&lt;0.05).

        Exclusion Criteria:

          -  History of delirium tremens, epilepsy, or withdrawal seizures

          -  Clinical depression or suicidality: Beck Depression Inventory (BDI) ≥ 16 and
             suicidality (Item G ≠ 0)

          -  Recent illicit drug use, i.e. cannabis, cocaine, amphetamines or opioids

          -  Clinically significant cardiovascular, hematologic, severe hepatic impairment

          -  History of psychosis, or current severe psychiatric disorder, e.g. schizophrenia,
             bipolar disorder, severe depression or organic brain syndrome unrelated to alcohol
             abuse

          -  Physical dependence on sedatives or hypnotics that requires pharmacologically
             supported detox

          -  Receiving ongoing alcohol use disorder medication (e.g. Baclofen)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Isabelle Lecomte, Dr</last_name>
    <phone>+33 1 47 03 66 30</phone>
    <email>i.lecomte@bioprojet.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Victoria Phamba</last_name>
    <phone>+33 1 47 03 66 30</phone>
    <email>v.phamba@bioprojet.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>State Psychiatric Hospital for Treatment of Drug Addiction and Alcoholism</name>
      <address>
        <city>Sofia</city>
        <zip>1303</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonya Toteva Zhenkova, Pr</last_name>
      <phone>+359 887 297 018</phone>
      <email>drtoteva@abv.bg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leningrad Regional Narcology Dispensary</name>
      <address>
        <city>Leningrad</city>
        <zip>188661</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Krupitsky Evgeny, Pr</last_name>
      <phone>007 (901) 300-5811</phone>
      <email>kruenator@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2018</study_first_submitted>
  <study_first_submitted_qc>February 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

